Top

Current Heart Failure Reports

Published in:

01-12-2004

Anemia and heart failure

Authors: Eileen O’Meara, MD, Clare Murphy, MBChB, John J. V. McMurray, MD

Published in: Current Heart Failure Reports | Issue 4/2004

Title: Anemia and heart failure
Authors: Eileen O’Meara, MD
Clare Murphy, MBChB
John J. V. McMurray, MD
Publication date: 01-12-2004
Publisher: Current Medicine Group
Published in: Current Heart Failure Reports / Issue 4/2004
Print ISSN: 1546-9530
Electronic ISSN: 1546-9549
DOI: https://doi.org/10.1007/s11897-004-0006-7

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2004

Current concepts for the neurohormonal management of left ventricular dysfunction after myocardial infarction

Aldosterone in heart failure: Pathophysiology and treatment

Atrial fibrillation post-myocardial infarction: Frequency, consequences, and management

Do statins prevent heart failure in patients after myocardial infarction?

Vasopressin antagonists in heart failure

Type 5 phosphodiesterase inhibition in heart failure and pulmonary hypertension

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage